For this first installment of a six webinar series, join Dr. Phillips and Dr. Litvack to hear how the experts are using live patient-specific tumor tissue to predict therapeutic response(s) in HGG patients before treatment initiation. HGG has an extremely poor prognosis leading to inevitable recurrence with limited biomarkers available to predict treatment responses. This interactive multidisciplinary cancer discussion will feature two real world clinical cases, presented by their treating physicians, with a discussion moderated by our panel of experts. There will be time for attendees to participate in Q&A. This Functional Precision Medicine Webinar Series is powered by OncoLens.